Delta Health Technologies, Inc.

Delta Health Technologies, Inc. delivers innovative software solutions that enhance operational efficiency for home health and hospice care providers across North America. Founded in 1968 and headquartered in Altoona, US, Delta Health Technologies, Inc. specializes in software solutions for the healthcare sector.

The company was acquired by AlayaCare Inc. on November 1, 2021. Shamim Ltd. serves as the CEO.

Delta Health Technologies specializes in providing advanced software solutions tailored for the healthcare sector, focusing on home health and hospice care providers. Their core offerings include the Crescendo™ platform and the AppointMate® scheduling tool, which streamline clinical and operational processes for healthcare organizations. These products enable efficient management of patient care, scheduling, and billing, addressing critical challenges such as compliance, documentation, and resource allocation. The target clientele includes home health agencies, hospice organizations, and other healthcare providers across the United States and Canada, enhancing operational efficiency and patient outcomes.

Delta Health Technologies generates revenue primarily through subscription-based models for its software solutions, allowing clients to access and utilize its products on an ongoing basis. Clients typically enter into service agreements defining terms of use, including support and updates, ensuring continuous engagement with the company's offerings. The revenue structure is supported by tiered pricing plans, where different levels of access and features are available based on the specific needs of healthcare providers. Flagship products like Crescendo™ and AppointMate® are central to their revenue generation strategy, fostering long-term relationships with clients and ensuring recurring revenue through sustained service contracts.

Delta Health Technologies plans to leverage its recent acquisition by AlayaCare Inc. to enhance its product offerings and expand its market reach. Upcoming products are currently in the design phase, with an emphasis on addressing emerging needs in home health and hospice care. The company aims to penetrate new geographic regions, particularly in Canada, by the end of 2023, utilizing funding from the acquisition to support these initiatives.